• Connect
  • Bookmark Us
  • AF Twitter
  • AF YouTube
  • AF LinkedIn
  • Subscribe
  • Subscription Link
Arent Fox
  • Firm

    • History

    • Awards & Recognitions

    • Diversity

      • Overview
      • Diversity Scholarship
      • Employees on Diversity
      • LGBT Initiative
      • Women’s Leadership Development Initiative
    • Alumni

    • Pro Bono

      • Overview
      • Current Pro Bono Work
      • Community Involvement
      • Pro Bono Newsletter
      • Pro Bono Awards & Honors
      • FAQ: Pro Bono & Working at Arent Fox
    • Leadership

      • Firm Management
      • Administrative Leadership
  • Deals & Cases

  • People

  • Practices & Industries

    • Practices

      • Advertising, Promotions & Data Security
      • Government Relations
      • Antitrust & Competition Law
      • Health Care
      • Appellate
      • Insurance & Reinsurance
      • Bankruptcy & Financial Restructuring
      • Intellectual Property
      • Commercial Litigation
      • International Trade
      • Communications, Technology & Mobile
      • Labor & Employment
      • Construction
      • Municipal & Project Finance
      • Consumer Product Safety
      • OSHA
      • Corporate & Securities
      • Political Law
      • ERISA
      • Real Estate
      • Environmental
      • Tax
      • FDA Practice (Food & Drug)
      • Wealth Planning & Management
      • Finance
      • White Collar & Investigations
      • Government Contractor Services
    • Industries

      • Automotive
      • Energy Law & Policy
      • Fashion, Luxury Goods & Retail
      • Government Real Estate & Public Buildings
      • Hospitality
      • Life Sciences
      • Long Term Care & Senior Living
      • Media & Entertainment
      • Medical Devices
      • Nonprofit
      • Sports
  • Newsroom

    • Alerts

    • Events

    • Media Mentions

    • Press Releases

    • Social Media

    • Subscribe

  • Careers

    • Lawyers

    • Law Students

    • Professional Staff

  • Contact

    • Washington, DC

    • New York, NY

    • Los Angeles, CA

    Alerts

    • Newsroom Overview
      • Alerts

        Alerts by Criteria

        E.g., 1 / 22 / 2013
        E.g., 1 / 22 / 2013
      • Events
      • Media Mentions
      • Press Releases
      • Social Media
      • Subscribe

    You are here

    Home » Newsroom » Alerts

    Share

    • Printer-friendly version
    • Send by email
    • A Title
    • A Title
    • A Title
    • A
    • A
    • A

    Comments Sought On FCC Petition Seeking Waiver of Frequency Monitoring Rules

    June 21, 2005

    The Federal Communications Commission is seeking comments from interested parties in the medical device and health care communities with regard to a request filed by DexCom, Inc. for a waiver of the FCC’s frequency monitoring requirements. These requirements apply to DexCom’s blood glucose monitoring system, a system that is regulated by the FCC’s Medical Implant Communications Service (MICS) rules. The resolution of this proceeding will greatly impact the following entities:

    • Medical device manufacturers subject to the MICS rules, and particularly the “listen before transmit requirement” contained in those rules.
    • Hospitals and health care providers concerned about the impact of the FCC’s frequency monitoring rules on patients requiring medical implants.

    In its Waiver Request, DexCom states that its system is comprised of two devices: a short-term blood glucose monitoring sensor (STS) device and a long-term blood glucose monitoring sensor (LTS) device. DexCom indicates that it has requested Food and Drug Administration pre-market approval for its STS device and that it plans by early next year to request similar approval for its LTS device. DexCom contends that, given the serious health and financial consequences of diabetics failing to manage their glucose levels adequately, the medical community and diabetics are anxious to have access to its system as soon as possible.

    However, DexCom states, its STS and LTS devices are incapable of satisfying the “listen before transmit” requirement that the MICS rules impose on all transmissions that do not constitute a medical implant event. DexCom therefore requests a waiver to permit its system to transmit periodically.

    The FCC is seeking comments from interested parties on the DexCom waiver. Initial comments must be filed by July 15, 2005, and Reply comments must be filed on or before August 1, 2005.

    Entities interested in participating in this proceeding, or learning more about the FCC’s regulation of medical devices, are invited to contact Jeffrey Rummel and Alan Fishel, of the firm’s Telecommunications practice group.

    Related People

    • Alan G. Fishel
    • Jeffrey E. Rummel

    Related Practices

    Communications, Technology & Mobile
    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Contact

    Footer Main

    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Subscribe
    • Alumni
    • Diversity
    • Legal Notice
    • Privacy Policy
    • Social Media Disclaimer
    • Nondiscrimination
    • Site Map
    • Client/Staff Login

    Offices

    • Washington, DC
      1717 K Street, NW
      Washington, DC 20036
      Tel: 202.857.6000
    • New York, NY
      1675 Broadway
      New York, New York 10019
      Tel: 212.484.3900
    • Los Angeles, CA
      555 West Fifth Street, 48th Floor
      Los Angeles, California 90013
      Tel: 213.629.7400
    • © Copyright 2013 Arent Fox LLP. All Rights Reserved.

      Legal Disclaimer
      Contents may contain attorney advertising under the laws of some states. Prior results do not guarantee a similar outcome.